Vivani Medical, Inc.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|
| Revenue | $6.9M | $8.0M | $4.0M | $8.9M | $3.4M | $1.6M |
| Cost of Revenue | $4.9M | $5.1M | $10.1M | $5.3M | $3.6M | $5.6M |
| Gross Profit | $2.0M | $2.8M | $-6.1M | $3.7M | $-160.0K | $-4.1M |
| Gross Margin | 29.1% | 35.7% | -152.3% | 41.1% | -4.7% | -259.7% |
| Operating Expenses | ||||||
| Research & Development | $10.0M | $7.9M | $5.3M | $3.0M | $5.0M | $3.2M |
| SG&A Expense | $10.7M | $10.9M | $10.1M | $8.2M | $6.6M | $4.2M |
| Operating Income | $-35.2M | $-28.6M | $-33.2M | $-20.0M | $-21.2M | $-18.0M |
| Operating Margin | -510.2% | -359.2% | -830.3% | -225.2% | -624.5% | -1,150.0% |
| Interest Expense | — | — | — | — | — | — |
| Pretax Income | — | — | — | — | — | — |
| Income Tax Expense | $0 | — | — | — | — | — |
| Net Income | $-35.1M | $-28.5M | $-33.2M | $-20.0M | $-35.2M | $-23.0M |
| Net Margin | -508.9% | -358.1% | -829.5% | -224.9% | -1,035.3% | -1,467.7% |
| EPS (Basic) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares Outstanding (Basic) | 10.31B | 62.30B | 46.16B | 38.9M | 38.1M | — |
| Shares Outstanding (Diluted) | 10.31B | 62.30B | 46.16B | 38.9M | 38.1M | — |
| Dividends Per Share | — | — | — | — | — | — |